(Q54061484)
Statements
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. (English)
1 reference
Hayek T
1 reference
Attias J
1 reference
Coleman R
1 reference
Brodsky S
1 reference
Smith J
1 reference
Breslow JL
1 reference
Keidar S
1 reference
1 December 1999
1 reference
44
1 reference
3
1 reference
579-587
1 reference
Identifiers
1 reference